Viking Therapeutics Cash from Investing (TTM) Analysis

Viking Therapeutics Inc (VKTX)

74.31 +5.45 (+7.91%) USD | NASDAQ | Apr 26, 16:00

74.69 +0.38 (+0.51%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2024	-641.08M
December 31, 2023	-179.09M
September 30, 2023	-207.56M
June 30, 2023	-168.13M
March 31, 2023	55.33M
December 31, 2022	54.75M
September 30, 2022	74.90M
June 30, 2022	61.63M
March 31, 2022	46.21M
December 31, 2021	37.96M
September 30, 2021	40.82M
June 30, 2021	17.57M
March 31, 2021	23.79M
December 31, 2020	41.57M
September 30, 2020	0.237M
June 30, 2020	25.02M
March 31, 2020	26.22M

Date	Value
December 31, 2019	7.463M
September 30, 2019	-123.87M
June 30, 2019	-166.11M
March 31, 2019	-243.71M
December 31, 2018	-265.73M
September 30, 2018	-127.73M
June 30, 2018	-99.26M
March 31, 2018	-33.40M
December 31, 2017	-1.73M
September 30, 2017	4.113M
June 30, 2017	3.162M
March 31, 2017	-0.9039M
December 31, 2016	3.030M
September 30, 2016	3.538M
June 30, 2016	-0.1545M
March 31, 2016	-7.497M
December 31, 2015	-13.47M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-641.08M

Minimum

Mar 2024

74.90M

Maximum

Sep 2022

-48.62M

Average

24.41M

Median

Cash from Investing (TTM) Benchmarks